mRNA-Based Therapies Face Raw Material and Manufacturing Challenges
The challenge has always been to find reputable suppliers to produce DNA at large scales.
Stay updated with breaking news from Vivienne Raper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The challenge has always been to find reputable suppliers to produce DNA at large scales.
Gold nanoparticle-based sensors could help companies with cell monitoring and quality control during biomanufacturing processes.
Lookingl at many medicines today, and the active ingredients that are required to produce them, a substantial fraction are still being sourced from nature.
Tips to Ensure Product Comparability in Gene Therapy Source: D-Keine/Getty Images Why is it important to study how manufacturing changes affect product quality? Heidaran: Gene therapies are complex, and the product is largely defined by the process, which means minor changes could potentially cause major changes in quality and efficacy. Development timelines are also quite compressed. Whereas you might have a 10- to 15-year development program for a small molecule or biologic, you can get some advanced therapies approved in around five years. There’s also quite a bit of process change invo...
These credits have been accumulated over the course of the year from dust jackets, Acknowledgments sections and copyright pages in works, cover reveal blog posts, and other sources on the internet. This year, Filers Martin Pyne and Karen B. also collected this information, and though we had a lot of overlap, their extra entries have greatly increased the information we are able to provide you. My profound thanks go to Martin and Karen for all of their hard work. You can see the full combined spreadsheet of Editor and Artist credits here (I will be continuing to update this as I get more inf...